Outcome of Percutaneous Ultrasound-guided Celiac Plexus Neurolysis for Managing Pain in Chronic Pancreatitis
DOI:
https://doi.org/10.62848/bjpain.v4i1.2281Keywords:
Celiac plexus, Neurolysis, Chronic pancreatitis, Chronic pain, VASAbstract
Background: Chronic pancreatitis is a debilitating condition often accompanied by severe pain. Ultrasound-guided celiac plexus neurolysis (CPN) has emerged as a potential technique for managing this pain. This study aims to evaluate the outcome of ultrasonography (USG) guided CPN in patients with chronic pancreatitis.
Methods: This prospective study was conducted from 2022 to 2023, including 10 patients diagnosed with chronic pancreatitis experiencing severe pain. All patients underwent USG-guided CPN. Pain relief was assessed using the Visual Analog Scale (VAS) before the procedure and at 1 week, 1 month, and 3 months post-procedure. Complications were recorded in a data sheet.
Results: A significant reduction in VAS scores was observed at all follow-up points compared to baseline. At 1 week, the mean VAS score decreased from 8.5 ± 1.2 to 3.2 ± 1.5 (p<0.001). At 1 month, the mean VAS score further decreased to 2.8 ± 1.3 (p<0.001), and at 3 months, it was 3.5 ± 1.6 (p<0.001). Mild complications, such as transient hypotension and diarrhoea, were reported in a few cases and treated accordingly. No severe complications were observed.
Conclusion: USG-guided celiac plexus neurolysis is an effective technique for managing pain in patients with chronic pancreatitis. Further long-term studies are recommended to explore the durability of pain relief.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Bangladesh Journal of Pain

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.